Abstract:In recent years, immunotherapy has developed rapidly as a new field of tumour therapy. However, the efficacy of tumour immunotherapy is not satisfactory due to the immune evasion mechanism of tumour cells, induction of immunosuppressive tumour microenvironment (TME), and reduction of antigen delivery, etc. CRISPR/Cas9 gene editing technology can accurately modify immune and tumour cells in tumours, and improve the efficacy of immunotherapy by targeting immune checkpoint molecules and immune regulatory genes, which has led to the great development and application. In current clinical trials, there are still many obstacles to the application of CRISPR/Cas9 in tumour immunotherapy, such as ensuring the accuracy and safety of gene editing, overcoming overreactive immune responses, and solving the challenges of in vivo drug delivery. Here we provide a systematic review on the application of CRISPR/Cas9 in tumour therapy to address the above existing problems. We focus on CRISPR/Cas9 screening and identification of immunomodulatory genes, targeting of immune checkpoint molecules, manipulation of immunomodulators, enhancement of tumour-specific antigen presentation and modulation of immune cell function. Second, we also highlight preclinical studies of CRISPR/Cas9 in animal models and various delivery systems, and evaluate the efficacy and safety of CRISPR/Cas9 technology in tumour immunotherapy. Finally, potential synergistic approaches for combining CRISPR/Cas9 knockdown with other immunotherapies are presented. This study underscores the transformative potential of CRISPR/Cas9 to reshape the landscape of tumour immunotherapy and provide insights into novel therapeutic strategies for cancer patients.

Applications and Advances of CRISPR-Cas9 in Cancer Immunotherapy

CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

CRISPR-Cas9 Genome Editing for Cancer Immunotherapy: Opportunities and Challenges.

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications

Improving Cancer Immunotherapy with CRISPR-Based Technology

Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy

CRISPR Applications in Cancer Diagnosis and Treatment

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy

The Potential Revolution of Cancer Treatment with CRISPR Technology

Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy

CRISPR/Cas9 Screening: Unraveling Cancer Immunotherapy's 'rosetta Stone'.

Application of CRISPR-Cas 9 system in cancer therapy

Advancements in CRISPR Screens for the Development of Cancer Immunotherapy Strategies

Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy